Renaissance Technologies LLC, under direction of Jim Simons has filed its 13F form on August 09, 2024 for Q2 2024 where it was disclosed a total value porftolio of $56.7 Billion distributed in 3444 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Novo Nordisk A S with a value of $1.31B, Palantir Technologies Inc. with a value of $1B, Nvidia Corp with a value of $867M, Vertex Pharmaceuticals Inc with a value of $734M, and United Therapeutics Corp with a value of $693M.
Examining the 13F form we can see an decrease of $6.93B in the current position value, from $63.6B to 56.7B.
Renaissance Technologies LLC is based out at New York, NY
Below you can find more details about Jim Simons portfolio as well as his latest detailed transactions.
Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.